CRT 2026
Innovation and Technology
Bernardo Cortese, MD, FESC, FSCAI
Director of Coronary Program
University Hospitals
Cleveland, Ohio, United States
Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Ricardo A. Costa, MD, PhD
Interventional Cardiologist - Percutaneous Intervention Research Medical Section Chief
Institute Dante Pazzanese of Cardiology
Sao Paulo, Sao Paulo, Brazil
Disclosure(s): No financial relationships to disclose
Bruno Scheller, MD
Professor of Clinical and Experimental Interventional Cardiology
University of Saarland
Homburg, Saarland, Germany
Disclosure(s): B.Braun: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); InnoRa GmbH: Owner/Co-Owner Founder/Co-Founder (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)